-
A novel intronic variant in MAPT causes FTLD-parkinsonism: Implications for regulatory mechanism of MAPT pre-mRNA splicing
-
A novel p.Trp42Arg REEP1 mutation associated with autosomal recessive Distal spinal muscular atrophy with vocal cord and diaphragmatic paralysis
-
A novel TGM6 heterozygous mutation in a patient with cerebellar ataxia
-
A Phase 2 Dose Escalation Study of Ampreloxetine (TD-9855), a Norepinephrine Reuptake Inhibitor, Given Once-Daily to Treat Neurogenic Orthostatic Hypotension (nOH) in Subjects with Synucleinopathies
-
A Phase 2 Study of the Efficacy, Durability and Safety of Ampreloxetine (TD-9855), a Norepinephrine Reuptake Inhibitor, Given Once-daily to Treat Neurogenic Orthostatic Hypotension (nOH) in Subjects with Synucleinopathies
-
A Phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson’s disease (STEADY-PD III): Final study results
-
A phase IIa trial studying the safety and tolerability of IRL752 in patients with Parkinson’s disease dementia
-
A Pilot Study of Gamma Knife Radiosurgery Targeting the Subthalamic Nucleus in Elderly and Infirmed Parkinson’s Disease Patients Not Amenable to Deep Brain Stimulation
-
A pilot study of the feasibility and effects of table tennis training in Parkinson’s Disease
-
A possible case of prodromal DLB with prominent hallucinations, autonomic dysfunction, and REM behavior disorder but absence of cognitive impairment
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 217
- Next Page »